Experts from Cedars-Sinai will present advances in research and clinical innovation at the annual Digestive Disease Week (DDW) scientific conference May 3-6 in San Diego.
Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinaiās Inflammatory Arthritis Clinical Center helps patients get back to the activities they enjoy.
Cedars-Sinai is a leading transplant center, with patient outcomes that consistently meet or exceed national averages. One continuing challenge, however, is the need to suppress transplant patientsā immune systems to prevent their bodies from rejecting the transplant.
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a special type of treatment for patients with certain cancers that have spread to the abdominal cavity (peritoneum).
Cedars-Sinai Orthopaedics has appointed new leadership for its sports medicine program, further strengthening the medical centerās position as a premier destination for orthopedic care.
Cedars-Sinai Department of Urology physician-investigators will present their latest research at the American Urological Association (AUA) Annual Meeting April 26-29 in Las Vegas.
Throughout Volunteer Appreciation Week, April 21-27, Cedars-Sinai is saluting its many outstanding volunteers and looking to add a few more to the corps.
Physician-scientists from Cedars-Sinai Cancer will present research at the American Association for Cancer Research annual meeting April 25-30 in Chicago.
The Cedars-Sinai Board of Governors Regenerative Medicine Institute is marking its 15th anniversary by further expanding its commitment to research, development of cell-based human models and therapies, and education with three new leadership appointments and the creation of a masterās degree program.
To mark National Volunteer Week, Cedars-Sinai is spotlighting two of the medical centerās youngest volunteers, who have a very special bond: They are identical twins.
An artificial intelligence (AI) program trained to review images from a common medical test can detect early signs of tricuspid heart valve disease and may help doctors diagnose and treat patients sooner, according to research from the Smidt Heart Institute at Cedars-Sinai.
Chris McCain was dying. He knew it. His wife, daughter and son also knew it. Years ago, at age 37, Chris had undergone a double lung transplant, but now those lungs were failing.
The latest research advances from Cedars-Sinai investigators.
Three cardiovascular experts in the Smidt Heart Institute at Cedars-Sinai received distinguished American College of Cardiology (ACC) and Journal of the American College of Cardiology (JACC) awards during the ACCās Annual Scientific Session on March 31 in Chicago.
A new Cedars-Sinai study demonstrates how gut bacteria can influence the development of blood vessel inflammation in laboratory mice. The findings, if confirmed in humans, would open a potential route for treating Kawasaki disease, a mysterious childhood disorder characterized by vascular inflammation.
Cedars-Sinai experts are participating in Abu Dhabi Global Health Week, April 15-17 in Abu Dhabi, United Arab Emirates (UAE). The conference is dedicated to fostering collaboration among clinicians and researchers, with the goal of enhancing healthcare worldwide.
Cedars-Sinai sports medicine specialist Casey G. Batten, MD, has been named chief medical officer for the LA28 Olympic and Paralympic Games in Los Angeles.
Patients hospitalized with opioid use disorders who receive addiction consultation services are significantly more likely to start medication treatment and access follow-up care when compared with patients who receive standard or usual care, a study co-led by Cedars-Sinai investigators found.
Do physicians or artificial intelligence (AI) offer better treatment recommendations for patients examined through a virtual urgent care setting? A new Cedars-Sinai study shows physicians and AI models have distinct strengths.
The hottest trend on the horizon for artificial intelligence (AI) is agentic AI, according to Jason Moore, PhD, chair of the Department of Computational Biomedicine at Cedars-Sinai
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right